Evidence for GRN connecting multiple neurodegenerative diseases

Area of Science:

• Neuroscience
• Genetics
• Inflammation research

Background:

• Genome-wide association studies (GWAS) have identified genetic variants associated with neurodegenerative disease risk.
• The common mechanistic links between different neurodegenerative diseases remain unclear.
• The gene GRN, encoding progranulin, is implicated in neurodegenerative conditions.

Purpose of the Study:

• To investigate the mechanistic interplay between genetic risk, gene expression, and inflammation involving the GRN gene.
• To explore shared mechanisms across Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis.
• To determine if GRN gene expression mediates neuroinflammation in these diseases.

Main Methods:

• Utilized genome-wide association studies (GWAS) and expression quantitative trait locus (eQTL) mapping.
• Performed Bayesian colocalization analyses to infer causal relationships.
• Integrated diverse molecular data from public resources for a data-driven approach.

Main Results:

• Significant associations found between GRN genetic risk and decreased GRN gene expression in the brain for Parkinson's, Alzheimer's, and ALS.
• Colocalization analyses revealed a link between platelet-related inflammatory biomarkers and GRN expression in the frontal cortex.
• GRN expression was identified as a mediator of neuroinflammation relevant to multiple neurodegenerative diseases.

Conclusions:

• Shared mechanistic pathways involving GRN gene expression and neuroinflammation likely contribute to Parkinson's, Alzheimer's, and ALS.
• Genetic variations in GRN may influence disease risk through altered gene expression and inflammatory responses.
• This study provides evidence for common biological underpinnings across distinct neurodegenerative diseases.